{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:41:48Z","timestamp":1789429308381,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Greek State Scholarships Foundation, IKY fellowships of excellence for postdoctoral studies in Greece-SIEMENS program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1038\/s41409-019-0501-9","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T15:03:39Z","timestamp":1552489419000},"page":"1963-1972","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinical-scale production of Aspergillus-specific T cells for the treatment of invasive aspergillosis in the immunocompromised host"],"prefix":"10.1038","volume":"54","author":[{"given":"Anastasia","family":"Papadopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Alvanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiriakos","family":"Koukoulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Athanasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriana","family":"Lazaridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Savvopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayotis","family":"Kaloyannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthi-Marina","family":"Markantonatou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timoleon-Achilleas","family":"Vyzantiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minas","family":"Yiangou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achilles","family":"Anagnostopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Yannaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"key":"501_CR1","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1086\/651263","volume":"50","author":"DP Kontoyiannis","year":"2010","unstructured":"Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010;50:1091\u2013100.","journal-title":"Clin Infect Dis"},{"key":"501_CR2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2217\/fmb.12.28","volume":"7","author":"S Shoham","year":"2012","unstructured":"Shoham S, Marr KA. Invasive fungal infections in solid organ transplant recipients. Future Microbiol. 2012;7:639\u201355.","journal-title":"Future Microbiol"},{"key":"501_CR3","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.3389\/fimmu.2017.01939","volume":"8","author":"PR Kumaresan","year":"2017","unstructured":"Kumaresan PR, da Silva TA, Kontoyiannis DP. Methods of controlling invasive fungal infections using CD8+T cells. Front Immunol. 2017;8:1939.","journal-title":"Front Immunol"},{"key":"501_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/bmt.2010.256","volume":"46","author":"DP Kontoyiannis","year":"2011","unstructured":"Kontoyiannis DP. Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success. Bone Marrow Transplant. 2011;46:165\u201373.","journal-title":"Bone Marrow Transplant"},{"key":"501_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/13693780701885552","volume":"46","author":"KA Marr","year":"2008","unstructured":"Marr KA. Fungal infections in hematopoietic stem cell transplant recipients. Med Mycol. 2008;46:293\u2013302.","journal-title":"Med Mycol"},{"key":"501_CR6","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1111\/j.1439-0507.2010.01903.x","volume":"54","author":"A Kim","year":"2011","unstructured":"Kim A, Nicolau DP, Kuti JL. Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States. Mycoses. 2011;54:e301\u201312.","journal-title":"Mycoses"},{"key":"501_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.critrevonc.2015.10.005","volume":"98","author":"A Papadopoulou","year":"2016","unstructured":"Papadopoulou A, Kaloyannidis P, Yannaki E, Cruz CR. Adoptive transfer of Aspergillus-specific T cells as a novel anti-fungal therapy for hematopoietic stem cell transplant recipients: progress and challenges. Crit Rev Oncol Hematol. 2016;98:62\u201372.","journal-title":"Crit Rev Oncol Hematol"},{"key":"501_CR8","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1182\/blood-2012-08-448977","volume":"121","author":"E Blyth","year":"2013","unstructured":"Blyth E, Clancy L, Simms R, Ma CKK, Burgess J, Deo S, et al. Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation. Blood. 2013;121:3745\u201358.","journal-title":"Blood"},{"key":"501_CR9","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1182\/blood-2016-01-628982","volume":"127","author":"CM Bollard","year":"2016","unstructured":"Bollard CM, Heslop HE. T cells for viral infections after allogeneic hematopoietic stem cell transplant. Blood. 2016;127:3331\u201340.","journal-title":"Blood"},{"key":"501_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","volume":"345","author":"CM Rooney","year":"1995","unstructured":"Rooney CM, Smith CA, Ng CY, Loftin S, Li C, Krance RA, et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet (Lond, Engl). 1995;345:9\u201313.","journal-title":"Lancet (Lond, Engl)"},{"key":"501_CR11","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","volume":"35","author":"I Tzannou","year":"2017","unstructured":"Tzannou I, Papadopoulou A, Naik S, Leung K, Martinez CA, Ramos CA, et al. Off-the-shelf virus-specific T cells to treat BK virus, human Herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation. J Clin Oncol. 2017;35:3547\u201357.","journal-title":"J Clin Oncol"},{"key":"501_CR12","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","volume":"333","author":"EA Walter","year":"1995","unstructured":"Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED, et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med. 1995;333:1038\u201344.","journal-title":"N Engl J Med"},{"key":"501_CR13","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1182\/blood-2011-08-371971","volume":"119","author":"E Doubrovina","year":"2012","unstructured":"Doubrovina E, Oflaz-Sozmen B, Prockop SE, Kernan NA, Abramson S, Teruya-Feldstein J, et al. Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+lymphomas after allogeneic hematopoietic cell transplantation. Blood. 2012;119:2644\u201356.","journal-title":"Blood"},{"key":"501_CR14","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","volume":"99","author":"H Einsele","year":"2002","unstructured":"Einsele H, Roosnek E, Rufer N, Sinzger C, Riegler S, L\u00f6ffler J, et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood. 2002;99:3916\u201322.","journal-title":"Blood"},{"key":"501_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2141.2006.06108.x","volume":"134","author":"T Feuchtinger","year":"2006","unstructured":"Feuchtinger T, Matthes-Martin S, Richard C, Lion T, Fuhrer M, Hamprecht K, et al. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol. 2006;134:64\u201376.","journal-title":"Br J Haematol"},{"key":"501_CR16","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1038\/mt.2013.151","volume":"21","author":"U Gerdemann","year":"2013","unstructured":"Gerdemann U, Katari UL, Papadopoulou A, Keirnan JM, Craddock JA, Liu H, et al. Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant. Mol Ther. 2013;21:2113\u201321.","journal-title":"Mol Ther"},{"key":"501_CR17","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1586\/ehm.12.38","volume":"5","author":"P Kaloyannidis","year":"2012","unstructured":"Kaloyannidis P, Leen AM, Papadopoulou A. T-cell therapy: a powerful tool for the management of viral infections and relapse post hematopoietic stem cell transplantation. Expert Rev Hematol. 2012;5:471\u20133.","journal-title":"Expert Rev Hematol"},{"key":"501_CR18","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/nm1475","volume":"12","author":"AM Leen","year":"2006","unstructured":"Leen AM, Myers GD, Sili U, Huls MH, Weiss H, Leung KS, et al. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med. 2006;12:1160\u20136.","journal-title":"Nat Med"},{"issue":"242","key":"501_CR19","doi-asserted-by":"publisher","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","volume":"6","author":"A. Papadopoulou","year":"2014","unstructured":"Papadopoulou A, Gerdemann U, Katari UL, Tzannou I, Liu H, Martinez C et al. Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. Sci Transl Med. 2014;6:242ra83.","journal-title":"Science Translational Medicine"},{"key":"501_CR20","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/S0140-6736(03)14634-X","volume":"362","author":"KS Peggs","year":"2003","unstructured":"Peggs KS, Verfuerth S, Pizzey A, Khan N, Guiver M, Moss PA, et al. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet. 2003;362:1375\u20137.","journal-title":"Lancet"},{"key":"501_CR21","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1182\/blood-2005-05-1775","volume":"106","author":"K Perruccio","year":"2005","unstructured":"Perruccio K, Tosti A, Burchielli E, Topini F, Ruggeri L, Carotti A, et al. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood. 2005;106:4397\u2013406.","journal-title":"Blood"},{"key":"501_CR22","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/mt.2012.130","volume":"20","author":"U Gerdemann","year":"2012","unstructured":"Gerdemann U, Keirnan JM, Katari UL, Yanagisawa R, Christin AS, Huye LE, et al. Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections. Mol Ther. 2012;20:1622\u201332.","journal-title":"Mol Ther"},{"key":"501_CR23","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B Pauw De","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813\u201321.","journal-title":"Clin Infect Dis"},{"key":"501_CR24","doi-asserted-by":"publisher","first-page":"10660","DOI":"10.1073\/pnas.1312789111","volume":"111","author":"PR Kumaresan","year":"2014","unstructured":"Kumaresan PR, Manuri PR, Albert ND, Maiti S, Singh H, Mi T, et al. Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection. Proc Natl Acad Sci USA. 2014;111:10660\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"501_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0976-500X.119726","volume":"4","author":"J Charan","year":"2013","unstructured":"Charan J, Kantharia N. How to calculate sample size in animal studies? J Pharmacol Pharmacother. 2013;4:303.","journal-title":"J Pharmacol Pharmacother"},{"key":"501_CR26","unstructured":"de Winter JCF. ERIC - using the Student\u2019s \u2018t\u2019-test with extremely small sample sizes.Pract Assess Res Eval. v18 n10. 2013. \nhttps:\/\/eric.ed.gov\/?id=EJ1015748."},{"key":"501_CR27","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1182\/blood-2010-12-322610","volume":"118","author":"N Khanna","year":"2011","unstructured":"Khanna N, Stuehler C, Conrad B, Lurati S, Krappmann S, Einsele H, et al. Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154. Blood. 2011;118:1121\u201331.","journal-title":"Blood"},{"key":"501_CR28","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1182\/blood-2003-12-4431","volume":"104","author":"AE Foster","year":"2004","unstructured":"Foster AE, Marangolo M, Sartor MM, Alexander SI, Hu M, Bradstock KF, et al. Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+naive T cells: potential for adoptive immunotherapy and allodepletion. Blood. 2004;104:2403\u20139.","journal-title":"Blood"},{"key":"501_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/myc.12318","volume":"58","author":"DE Corzo-Le\u00f3n","year":"2015","unstructured":"Corzo-Le\u00f3n DE, Satlin MJ, Soave R, Shore TB, Schuetz AN, Jacobs SE, et al. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens. Mycoses. 2015;58:325\u201336.","journal-title":"Mycoses"},{"key":"501_CR30","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/myc.12643","volume":"60","author":"S Wurster","year":"2017","unstructured":"Wurster S, Weis P, Page L, Helm J, Lazariotou M, Einsele H, et al. Intra- and inter-individual variability of Aspergillus fumigatus reactive T-cell frequencies in healthy volunteers in dependency of mould exposure in residential and working environment. Mycoses. 2017;60:668\u201375.","journal-title":"Mycoses"},{"key":"501_CR31","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrmicro.2017.90","volume":"15","author":"FL Veerdonk van de","year":"2017","unstructured":"van de Veerdonk FL, Gresnigt MS, Romani L, Netea MG, Latg\u00e9 J-P. Aspergillus fumigatus morphology and dynamic host interactions. Nat Rev Microbiol. 2017;15:661\u201374.","journal-title":"Nat Rev Microbiol"},{"key":"501_CR32","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/infdis\/jix469","volume":"216","author":"E Stephen-Victor","year":"2017","unstructured":"Stephen-Victor E, Karnam A, Fontaine T, Beauvais A, Das M, Hegde P, et al. Aspergillus fumigatus cell wall \u03b1-(1,3)-glucan stimulates regulatory T-cell polarization by inducing PD-L1 expression on human dendritic cells. J Infect Dis. 2017;216:1281\u201394.","journal-title":"J Infect Dis"},{"key":"501_CR33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4049\/jimmunol.165.1.381","volume":"165","author":"E Cenci","year":"2000","unstructured":"Cenci E, Mencacci A, Bacci A, Bistoni F, Kurup VP, Romani L. T cell vaccination in mice with invasive pulmonary aspergillosis. J Immunol. 2000;165:381\u20138.","journal-title":"J Immunol"},{"key":"501_CR34","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.jcyt.2015.05.011","volume":"17","author":"P Bacher","year":"2015","unstructured":"Bacher P, Jochheim-Richter A, Mockel-Tenbrink N, Kniemeyer O, Wingenfeld E, Alex R, et al. Clinical-scale isolation of the total Aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer. Cytotherapy. 2015;17:1396\u2013405.","journal-title":"Cytotherapy"},{"key":"501_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jcyt.2015.09.013","volume":"18","author":"SS Deo","year":"2016","unstructured":"Deo SS, Virassamy B, Halliday C, Clancy L, Chen S, Meyer W, et al. Stimulation with lysates of Aspergillus terreus, Candida krusei and Rhizopus oryzae maximizes cross-reactivity of anti-fungal T cells. Cytotherapy. 2016;18:65\u201379.","journal-title":"Cytotherapy"},{"key":"501_CR36","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3109\/14653249.2012.704013","volume":"14","author":"SS Gaundar","year":"2012","unstructured":"Gaundar SS, Clancy L, Blyth E, Meyer W, Gottlieb DJ. Robust polyfunctional T-helper 1 responses to multiple fungal antigens from a cell population generated using an environmental strain of Aspergillus fumigatus. Cytotherapy. 2012;14:1119\u201330.","journal-title":"Cytotherapy"},{"key":"501_CR37","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jcyt.2012.11.014","volume":"15","author":"L Tramsen","year":"2013","unstructured":"Tramsen L, Schmidt S, Boenig H, Latg\u00e9 J-P, Lass-Fl\u00f6rl C, Roeger F, et al. Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes. Cytotherapy. 2013;15:344\u201351.","journal-title":"Cytotherapy"},{"key":"501_CR38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2249.2007.03544.x","volume":"151","author":"F Zhu","year":"2008","unstructured":"Zhu F, Ramadan G, Davies B, Margolis DA, Keever-Taylor CA. Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses. Clin Exp Immunol. 2008;151:284\u201396.","journal-title":"Clin Exp Immunol"},{"key":"501_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1365-2249.2005.02738.x","volume":"140","author":"G Ramadan","year":"2005","unstructured":"Ramadan G, Davies B, Kurup VP, Keever-Taylor CA. Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen. Clin Exp Immunol. 2005;140:81\u201391.","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"501_CR40","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/infdis\/jiu607","volume":"211","author":"Claudia Stuehler","year":"2014","unstructured":"Stuehler C, Nowakowska J, Bernardini C, Topp MS, Battegay M, Passweg J, et al. Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections. J Infect Dis. 2015;211:1251\u201361. \nhttps:\/\/doi.org\/10.1093\/infdis\/jiu607\n\n.","journal-title":"The Journal of Infectious Diseases"},{"key":"501_CR41","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.4049\/jimmunol.0900961","volume":"183","author":"S Bozza","year":"2009","unstructured":"Bozza S, Clavaud C, Giovannini G, Fontaine T, Beauvais A, Sarfati J, et al. Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination. J Immunol. 2009;183:2407\u201314.","journal-title":"J Immunol"},{"key":"501_CR42","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.4049\/jimmunol.1400776","volume":"193","author":"P Bacher","year":"2014","unstructured":"Bacher P, Kniemeyer O, Teutschbein J, Th\u00f6n M, V\u00f6disch M, Wartenberg D, et al. Identification of immunogenic antigens from Aspergillus fumigatus by direct multiparameter characterization of specific conventional and regulatory CD4+T cells. J Immunol. 2014;193:3332\u201343.","journal-title":"J Immunol"},{"key":"501_CR43","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1182\/blood-2005-04-1660","volume":"107","author":"O Beck","year":"2006","unstructured":"Beck O, Topp MS, Koehl U, Roilides E, Simitsopoulou M, Hanisch M, et al. Generation of highly purified and functionally active human TH1 cells against Aspergillus fumigatus. Blood. 2006;107:2562\u20139.","journal-title":"Blood"},{"key":"501_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/bmt.2008.271","volume":"43","author":"L Tramsen","year":"2009","unstructured":"Tramsen L, Koehl U, Tonn T, Latg\u00e9 J-P, Schuster FR, Borkhardt A, et al. Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy. Bone Marrow Transplant. 2009;43:13\u20139.","journal-title":"Bone Marrow Transplant"},{"key":"501_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nri2939","volume":"11","author":"L Romani","year":"2011","unstructured":"Romani L. Immunity to fungal infections. Nat Rev Immunol. 2011;11:275\u201388.","journal-title":"Nat Rev Immunol"},{"key":"501_CR46","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1172\/JCI58762","volume":"122","author":"SG Nanjappa","year":"2012","unstructured":"Nanjappa SG, Heninger E, W\u00fcthrich M, Sullivan T, Klein B. Protective antifungal memory CD8(+) T cells are maintained in the absence of CD4(\u2009+\u2009) T cell help and cognate antigen in mice. J Clin Invest. 2012;122:987\u201399.","journal-title":"J Clin Invest"},{"key":"501_CR47","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1182\/blood-2011-06-362582","volume":"119","author":"A Carvalho","year":"2012","unstructured":"Carvalho A, De Luca A, Bozza S, Cunha C, D\u2019Angelo C, Moretti S, et al. TLR3 essentially promotes protective class I-restricted memory CD8+ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. Blood. 2012;119:967\u201377.","journal-title":"Blood"},{"key":"501_CR48","doi-asserted-by":"publisher","first-page":"e74326","DOI":"10.1371\/journal.pone.0074326","volume":"8","author":"L Potenza","year":"2013","unstructured":"Potenza L, Vallerini D, Barozzi P, Riva G, Forghieri F, Beauvais A, et al. Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patients. PLoS ONE 2013;8:e74326.","journal-title":"PLoS One"},{"issue":"4","key":"501_CR49","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/cid\/ciy549","volume":"68","author":"Corey Smith","year":"2018","unstructured":"Smith C, Beagley L, Rehan S, Neller MA, Crooks P, Solomon M, et al. Autologous adoptive T-cell therapy for recurrent or drug-resistant cytomegalovirus complications in solid organ transplant recipients: a single-arm open-label phase I clinical trial. Clin Infect Dis. 2019;68:632\u201340. \nhttps:\/\/doi.org\/10.1093\/cid\/ciy549\n\n.","journal-title":"Clinical Infectious Diseases"},{"key":"501_CR50","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1182\/blood-2004-09-3421","volume":"105","author":"M Stanzani","year":"2005","unstructured":"Stanzani M, Orciuolo E, Lewis R, Kontoyiannis DP, Martins SLR, St, John LS, et al. Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. Blood. 2005;105:2258\u201365.","journal-title":"Blood"},{"key":"501_CR51","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1086\/374646","volume":"187","author":"AP Campanelli","year":"2003","unstructured":"Campanelli AP, Martins GA, Souto JT, Pereira MSF, Livonesi MC, Martinez R, et al. Fas\u2010Fas ligand (CD95\u2010CD95L) and cytotoxic T lymphocyte antigen\u20134 engagement mediate T cell unresponsiveness in patients with paracoccidioidomycosis. J Infect Dis. 2003;187:1496\u2013505.","journal-title":"J Infect Dis"},{"key":"501_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/cc12711","volume":"17","author":"KC Chang","year":"2013","unstructured":"Chang KC, Burnham C-A, Compton SM, Rasche DP, Mazuski R, SMcDonough J, et al. Blockade ofthe negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis. Crit Care. 2013;17:R85.","journal-title":"Crit Care"},{"key":"501_CR53","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/S1470-2045(17)30852-5","volume":"18","author":"N Daver","year":"2017","unstructured":"Daver N, Kontoyiannis DP. Checkpoint inhibitors and aspergillosis in AML: the double hit hypothesis. Lancet Oncol. 2017;18:1571\u20133.","journal-title":"Lancet Oncol"}],"updated-by":[{"DOI":"10.1038\/s41409-019-0592-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000}}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0501-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0501-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0501-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:14:23Z","timestamp":1684617263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-019-0501-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,13]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["501"],"URL":"https:\/\/doi.org\/10.1038\/s41409-019-0501-9","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41409-019-0592-3","asserted-by":"object"}]},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,13]]},"assertion":[{"value":"7 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2019","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}